PreprintLicence not statedChemRxiv
Active Learning for Fragment-Based Kinase Inhibitor Discovery using Docking
- 1Data Driven Drug Design
- 2Saarland University
- 3Helmholtz Institute for Pharmaceutical Research Saarland
Related
- Docking, Molecular Dynamics, QSAR, and Machine Learning in Alzheimer's Small-Molecule Drug Discovery: Current Utility, Key Limitations, and Reproducibility Challenges
- MLIP Detective: Active Failure Mode Discovery Beyond Benchmark Scores for Machine-Learning Interatomic Potentials
- Linear inductive bias boosts extrapolative molecular discovery by Bayesian active learning in the small-data limit
- An Active Learning Framework for PFAS-Free Surfactant Discovery in Firefighting Foams
- GCMDiff: a condition-guided diffusion framework for pharmacophore-fragment drug discovery and target-specific molecular design
BibTeX
@misc{kramer2026active,
title = {{Active Learning for Fragment-Based Kinase Inhibitor Discovery using Docking}},
author = {Paula Linh Kramer and Michael Backenköhler and Andrea Volkamer},
howpublished = {ChemRxiv},
year = {2026},
month = nov,
doi = {10.26434/chemrxiv.15011770/v1},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011770/v1},
}
RIS
TY - UNPB
TI - Active Learning for Fragment-Based Kinase Inhibitor Discovery using Docking
AU - Paula Linh Kramer
AU - Michael Backenköhler
AU - Andrea Volkamer
PY - 2026
DA - 2026/11/05
PB - ChemRxiv
DO - 10.26434/chemrxiv.15011770/v1
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011770/v1
ER -